IQVIA Holdings Inc. IQV

IQV Company Overview

IQVIA Holdings Inc. is a global provider of advanced analytics, technology solutions, and clinical research services primarily serving the life sciences and healthcare industries. The company operates at the intersection of healthcare data, contract research, and technology-enabled commercialization services, helping pharmaceutical, biotechnology, medical device, and healthcare organizations develop and market therapies. IQVIA was formed through the 2016 merger of Quintiles Transnational Holdings and IMS Health Holdings, combining one of the world’s largest contract research organizations with a major healthcare information and analytics provider. The company is publicly traded on the New York Stock Exchange under the ticker IQV.

IQVIA’s primary revenue drivers include clinical trial management, healthcare data analytics, real-world evidence solutions, commercial outsourcing services, and software platforms used across drug development and commercialization workflows. The company’s strategic positioning is supported by its large-scale healthcare data assets, global clinical research infrastructure, and integrated technology platforms that connect clinical, commercial, and regulatory functions. IQVIA serves customers across pharmaceutical manufacturing, biotechnology, government healthcare agencies, payers, and provider organizations, with particular strength among large multinational biopharmaceutical companies.